BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1310836)

  • 21. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
    Huchet J; Brossard Y
    Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
    [No Abstract]   [Full Text] [Related]  

  • 22. Why women are not receiving anti-Rh prophylaxis.
    Hussey RM
    Br Med J (Clin Res Ed); 1987 Jan; 294(6564):119. PubMed ID: 3032323
    [No Abstract]   [Full Text] [Related]  

  • 23. Rh immune globulin prophylaxis for threatened abortions.
    Kuller JA
    Am J Obstet Gynecol; 1991 Feb; 164(2):703-4. PubMed ID: 1899535
    [No Abstract]   [Full Text] [Related]  

  • 24. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advantages of preventing Rh isoimmunization].
    Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
    Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why women are not receiving anti-Rh prophylaxis.
    Tovey LA
    Br Med J (Clin Res Ed); 1987 Feb; 294(6570):508. PubMed ID: 3030482
    [No Abstract]   [Full Text] [Related]  

  • 27. Antenatal Rh immunoglobulin--help or hindrance?
    Pisciotto P; Gorbants I; Sundra M
    Transfusion; 1985; 25(1):88. PubMed ID: 2982225
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.
    Slootweg YM; Zwiers C; Koelewijn JM; van der Schoot E; Oepkes D; van Kamp IL; de Haas M
    BJOG; 2022 Sep; 129(10):1721-1730. PubMed ID: 35133072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].
    Högman C; Nilsson BA
    Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
    Hensleigh PA
    Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance in appropriate Rh testing and treatment with Rh immunoglobulin in the emergency department.
    Griffey RT; Chen BC; Krehbiel NW
    Ann Emerg Med; 2012 Apr; 59(4):285-93. PubMed ID: 22153971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated anti-D titer after the administration of Rh immune globulin. A case report.
    Andres RL; Branch DW; Scott JR
    J Reprod Med; 1989 Apr; 34(4):318-20. PubMed ID: 2497253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study.
    Gilmore EV; Russell LB; Harvie HS; Schreiber CA
    Contraception; 2024 Aug; 136():110468. PubMed ID: 38648923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal-maternal bleed in the second trimester of pregnancy. A report of two cases.
    Gass ML; Carey PM
    J Reprod Med; 1992 Apr; 37(4):378-80. PubMed ID: 1317453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Has anti-D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?
    Dillon A; Chaudhari T; Crispin P; Shadbolt B; Kent A
    J Paediatr Child Health; 2011 Jan; 47(1-2):40-3. PubMed ID: 20973864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antenatal Rh iso-immunization prophylaxis: implications for blood bank assessment.
    Larison J; Fadel H; Squires J; Barnwell C
    J Med Assoc Ga; 1985 Aug; 74(8):560-1. PubMed ID: 2995529
    [No Abstract]   [Full Text] [Related]  

  • 40. Costs and benefits of non-invasive fetal RhD determination.
    Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.